Abstract: Novel compounds of unstable inhibitors of the serine peptidase dipeptidyl peptidase IV, are used in the treatment of various disorders, especially of metabolic disorders. The compounds can be used in the treatment of impaired glucose tolerance, glucosuria, hyperlipidaemia, metabolic acidoses, diabetes mellitus, diabetic neuropathy and nephropathy.
Type:
Grant
Filed:
December 21, 2000
Date of Patent:
May 30, 2006
Assignee:
Prosidion Ltd.
Inventors:
Hans-Ulrich Demuth, Jorn Schmidt, Torsten Hoffmann, Konrad Glund